kt-621
·Code: KT-621
kt-621: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Kymera Therapeutics, Inc. (KYMR) | Phase 2 |
Get deeper analysis on kt-621
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis